Total Funding
64
40
Total FundingPost-IPO Equity raised
Growth Score
-30 pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
119710
PolyPid offers a technology platform that enables a controlled and prolonged release of any active pharmaceutical ingredients (API).
Amir Weisberg: CEO
Shaun Marcus: CFO
About the Company
PolyPid is a development stage company that has developed a platform technology for the healthcare industry that enables a controlled and prolonged release of any active pharmaceutical ingredients (API).
PolyPid’s technology combines polymers and lipids, enabling small-and-large API entrapment in degradation and hydration protected environments,
regardless of their chemical or physical characteristics.
PolyPid allows the release of the API from the reservoir at pre-determined rates of up to several months, with a constant release rate (zero-order kinetics). The flexibility of this innovative technology enables local administration of compounds across numerous therapeutic classes for several applications.
